Dna Group (T.R.) Ltd (DNA.TA)
ILA 116.2
(6.02%)
ILA 116.2
(6.02%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.47 Million ILS | -21.84% |
| 2022 | 1.88 Million ILS | 555.75% |
| 2021 | 287 Thousand ILS | -97.28% |
| 2020 | 10.54 Million ILS | 23.3% |
| 2019 | 8.55 Million ILS | -45.92% |
| 2018 | 15.81 Million ILS | 75.94% |
| 2017 | 8.98 Million ILS | -92.61% |
| 2016 | 121.58 Million ILS | 8.2% |
| 2015 | 112.37 Million ILS | 22.85% |
| 2014 | 91.46 Million ILS | 894.87% |
| 2013 | 9.19 Million ILS | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 1.3 Million ILS | -11.62% |
| 2024 Q2 | 1.3 Million ILS | 0.0% |
| 2023 Q2 | 1.66 Million ILS | 129.48% |
| 2023 Q1 | 726 Thousand ILS | -61.42% |
| 2023 Q4 | 1.47 Million ILS | 114.74% |
| 2023 Q3 | 685 Thousand ILS | -58.88% |
| 2023 FY | 1.47 Million ILS | -21.84% |
| 2022 Q1 | 457 Thousand ILS | 59.23% |
| 2022 FY | 1.88 Million ILS | 555.75% |
| 2022 Q3 | 789 Thousand ILS | 72.65% |
| 2022 Q4 | 1.88 Million ILS | 138.53% |
| 2022 Q2 | 457 Thousand ILS | 0.0% |
| 2021 Q3 | 287 Thousand ILS | -89.67% |
| 2021 FY | 287 Thousand ILS | -97.28% |
| 2021 Q4 | 287 Thousand ILS | 0.0% |
| 2021 Q1 | 2.77 Million ILS | -73.65% |
| 2021 Q2 | 2.77 Million ILS | 0.0% |
| 2020 Q2 | 9.55 Million ILS | 0.0% |
| 2020 Q4 | 10.54 Million ILS | 0.0% |
| 2020 Q1 | 9.55 Million ILS | 11.69% |
| 2020 FY | 10.54 Million ILS | 23.3% |
| 2020 Q3 | 10.54 Million ILS | 10.39% |
| 2019 Q4 | 8.55 Million ILS | 0.0% |
| 2019 Q1 | 13.82 Million ILS | -12.55% |
| 2019 Q2 | 13.82 Million ILS | 0.0% |
| 2019 Q3 | 8.55 Million ILS | -38.16% |
| 2019 FY | 8.55 Million ILS | -45.92% |
| 2018 Q3 | 15.81 Million ILS | -23.82% |
| 2018 FY | 15.81 Million ILS | 75.94% |
| 2018 Q1 | 20.75 Million ILS | 130.97% |
| 2018 Q4 | 15.81 Million ILS | 0.0% |
| 2018 Q2 | 20.75 Million ILS | 0.0% |
| 2017 Q1 | 927 Thousand ILS | -99.24% |
| 2017 Q2 | 927 Thousand ILS | 0.0% |
| 2017 Q3 | 8.98 Million ILS | 869.47% |
| 2017 Q4 | 8.98 Million ILS | 0.0% |
| 2017 FY | 8.98 Million ILS | -92.61% |
| 2016 Q2 | 124.3 Million ILS | 37.28% |
| 2016 Q4 | 121.58 Million ILS | 0.15% |
| 2016 Q3 | 121.4 Million ILS | -2.33% |
| 2016 FY | 121.58 Million ILS | 8.2% |
| 2016 Q1 | 90.54 Million ILS | -19.42% |
| 2015 Q4 | 112.37 Million ILS | -1.23% |
| 2015 Q1 | 29.9 Million ILS | -67.3% |
| 2015 Q3 | 113.77 Million ILS | 16.37% |
| 2015 FY | 112.37 Million ILS | 22.85% |
| 2015 Q2 | 97.76 Million ILS | 226.9% |
| 2014 FY | 91.46 Million ILS | 894.87% |
| 2014 Q1 | 9.16 Million ILS | -0.34% |
| 2014 Q4 | 91.46 Million ILS | 984.0% |
| 2014 Q2 | 8.57 Million ILS | -6.46% |
| 2014 Q3 | 8.43 Million ILS | -1.55% |
| 2013 Q1 | 10.81 Million ILS | 0.0% |
| 2013 FY | 9.19 Million ILS | 0.0% |
| 2013 Q2 | 10.17 Million ILS | -5.9% |
| 2013 Q3 | 9.65 Million ILS | -5.16% |
| 2013 Q4 | 9.19 Million ILS | -4.74% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Matricelf Ltd | 3.7 Million ILA | 60.243% |